US FDA rejects AbbVie’s wrinkle treatment due to manufacturing concerns

Investing.com Gold reports: US FDA rejects AbbVie’s wrinkle treatment due to manufacturing concerns. Full body text was unavailable at ingest time, so this brief is based on headline context.